Aseptic Technologies specializes in advanced aseptic filling solutions tailored for the biotechnology and pharmaceutical sectors, particularly focusing on cell and gene therapies. Their flagship product, the AT-Closed Vial® technology, is designed to ensure contamination-free filling processes, which is critical for the safe administration of injectable therapies. The company offers customizable, single-use systems like the AT-Filling Kit™, which facilitates high-accuracy filling from bulk products into vials, while minimizing validation and inventory management efforts. This system is optimized for various vial sizes and is manufactured in ISO 7 cleanrooms, ensuring compliance with stringent industry standards.

In addition to their filling solutions, Aseptic Technologies provides the AT-Adapt™, a needle-less collection device that enhances patient safety by simplifying the administration of therapies. This device is designed for use in diverse healthcare environments, allowing for easy access to the AT-Closed Vial® without the need for needles. The company emphasizes the importance of user-friendly standard operating procedures (SOPs) and devices to ensure error-proof administration, thereby maximizing clinical outcomes. Through their innovative technologies, Aseptic Technologies aims to support biotech companies in delivering transformative treatments to patients efficiently and safely.

United States

Aseptic Technologies develops, manufactures and markets equipment that guarantee optimal sterility assurance level and complies with latest regulatory requirements, while simplifying the validation and operation processes in the safest way.
Aseptic Technologies improves the quality of aseptic operations by providing user-oriented and really innovative state-of-the-art equipment and services to the pharmaceutical industry.

Aseptic Technologies

Company Details